Earnings Scheduled For May 10, 2023
Companies Reporting Before The Bell
• Nomad Foods (NYSE:NOMD) is projected to report quarterly earnings at $0.42 per share on revenue of $851.81 million.
Earnings Outlook For scPharmaceuticals
scPharmaceuticals (NASDAQ:SCPH) is set to give its latest quarterly earnings report on Wednesday, 2023-05-10. Here’s what investors need…
Dow Up 150 Points; Gold Jumps Over 2%
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining around 150 points on Thursday.
The Dow traded up 0.47% to 32,180.26 while the NASDAQ rose 1.29% to 11,820.77. The S&P 500, also rose, gaining, 0.67% to 3,963.50.
12 Health Care Stocks Moving In Thursday’s Intraday Session
Gainers ZyVersa Therapeutics (NASDAQ:ZVSA) shares increased by 31.4% to $2.14 during Thursday’s regular session. As of 13:30 EST,…
Why Block Shares Are Trading Lower By Over 13%? Here Are Other Stocks Moving In Thursday’s Mid-Day Session
Gainers
DiamondHead Holdings Corp. (NASDAQ: DHHC) shares jumped 104.2% to $21.15. DiamondHead entered into convertible note purchase agreement dated March 21, 2023.
Nasdaq Surges Over 2%; Accenture To Reduce 19,000 Jobs
U.S. stocks traded higher midway through trading, with the Dow Jones gaining around 450 points on Thursday.
The Dow traded up 1.42% to 32,484.03 while the NASDAQ rose 2.40% to 11,949.60. The S&P 500, also rose, gaining, 1.70% to 4,004.07.
KB Home, Accenture, Netflix And Other Big Stocks Moving Higher On Thursday
U.S. stocks traded higher, with the Dow Jones gaining around 200 points on Thursday. Here are some big stocks recording gains in today’s session.
ScPharmaceuticals Announces Co Is Targeting February 20, 2023 As The Date For Commercial Availability Of FUROSCIX
scPharmaceuticals Inc. (NASDAQ:SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize therapies, advance patient care, and reduce healthcare costs, today
SVB Leerink Maintains Outperform on scPharmaceuticals, Raises Price Target to $13
SVB Leerink analyst Roanna Ruiz maintains scPharmaceuticals (NASDAQ:SCPH) with a Outperform and raises the price target from $12 to $13.
Benzinga’s Top Ratings Upgrades, Downgrades For December 1, 2022
Upgrades Northcoast Research upgraded the previous rating for SpartanNash Co (NASDAQ:SPTN) from Neutral to Buy. SpartanNash earned $0.55…